Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer for which no early diagnostic method is available. The immune surveillance hypothesis suggests that the immune system plays crucial roles in tumor development and progression. We validated a PDAC-specific biomarker derived from peripher...
Main Authors: | Sung-Ill Jang, Jae-Hee Cho, So-Young Kim, In-Young Hong, Joon-Seong Park, Hye-Sun Lee, Goeun Park, Jong-Kyoung Kim, Hyung-Keun Lee, Dong-Ki Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/3/853 |
Similar Items
-
Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma
by: Youngil Koh, et al.
Published: (2023-10-01) -
Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
by: Gitika Thakur, et al.
Published: (2021-02-01) -
Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location
by: Min Kyu Sung, et al.
Published: (2021-11-01) -
Sclerosing encapsulating peritonitis in a dog with pancreatic ductal adenocarcinoma
by: Yusuke Tsukada, et al.
Published: (2022-11-01) -
Characterization of Circulating IL-7R Positive Cell Populations for Early Detection of Pancreatic Ductal Adenocarcinoma
by: Sun-Hee Heo, et al.
Published: (2021-09-01)